Evidence map›Paper›PMID 29844323›Full record

ArticleScientific reports2018

Naturally occurring a loss of a giant plasmid from Mycobacterium ulcerans subsp. shinshuense makes it non-pathogenic.

Kazue Nakanaga, Yoshitoshi Ogura, Atsushi Toyoda, Mitsunori Yoshida, Hanako Fukano, Nagatoshi Fujiwara, Yuji Miyamoto, Noboru Nakata, Yuko Kazumi, Shinji Maeda and 9 more

Abstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Variable Number Tandem Repeat Profiling ofFrontiers in microbiology · 2022
    Article
  8. ComprehensiveMicrobial genomics · 2021
    Article
  9. Point mutation in the stop codon ofMicrobiology (Reading, England) · 2021
    Article
  10. Human genetics of Buruli ulcer.Human genetics · 2020
    Review
  11. Pharmacologic management ofExpert review of clinical pharmacology · 2020
    Review
  12. In Vivo Imaging of BioluminescentThe American journal of tropical medicine and hygiene · 2019
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Kazue NakanagaDepartment of Mycobacteriology, Leprosy Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Yoshitoshi OguraDepartment of Bacteriology, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
Atsushi ToyodaCenter for Information Biology, National Institute of Genetics, Shizuoka, Japan.ORCID 0000-0002-0728-7548
Mitsunori YoshidaDepartment of Mycobacteriology, Leprosy Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Hanako FukanoDepartment of Mycobacteriology, Leprosy Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Nagatoshi FujiwaraDepartment of Food and Nutrition, Faculty of Contemporary Human Life Science, Tezukayama University, Nara, Japan.
Yuji MiyamotoDepartment of Mycobacteriology, Leprosy Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Noboru NakataDepartment of Mycobacteriology, Leprosy Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Yuko KazumiAntimicrobial Resistance Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Shinji MaedaThe Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Tokyo, Japan.
Tadasuke OokaDepartment of Microbiology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.
Masamichi GotoNational Sanatorium Hoshizuka-Keiaien, Kagoshima, Japan.
Kazunari TanigawaDepartment of Mycobacteriology, Leprosy Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Satoshi MitaraiThe Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Tokyo, Japan.
Koichi SuzukiDepartment of Mycobacteriology, Leprosy Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Norihisa IshiiDepartment of Mycobacteriology, Leprosy Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Manabu AtoDepartment of Mycobacteriology, Leprosy Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Tetsuya HayashiDepartment of Bacteriology, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
Yoshihiko HoshinoDepartment of Mycobacteriology, Leprosy Research Center, National Institute of Infectious Diseases, Tokyo, Japan. yhoshino@nih.go.jp.ORCID 0000-0002-3132-0715

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mycobacterium ulcerans is the causative agent of Buruli ulcer (BU), a WHO-defined neglected tropical disease. All Japanese BU causative isolates have shown distinct differences from the prototype and are categorized as M. ulcerans subspecies shinshuense. During repeated sub-culture, we found that some M. shinshuense colonies were non-pigmented whereas others were pigmented. Whole genome sequence analysis revealed that non-pigmented colonies did not harbor a giant plasmid, which encodes elements needed for mycolactone toxin biosynthesis. Moreover, mycolactone was not detected in sterile filtrates of non-pigmented colonies. Mice inoculated with suspensions of pigmented colonies died within 5 weeks whereas those infected with suspensions of non-pigmented colonies had significantly prolonged survival (>8 weeks). This study suggests that mycolactone is a critical M. shinshuense virulence factor and that the lack of a mycolactone-producing giant plasmid makes the strain non-pathogenic. We made an avirulent mycolactone-deletion mutant strain directly from the virulent original.

Indexed as

PlasmidsAnimalsBuruli UlcerChromosomes, BacterialCulture MediaGenes, BacterialMacrolidesMiceMice, Inbred BALB CMycobacterium ulceransVirulenceCulture MediaMacrolidesmycolactone

Identifiers

PMID29844323
PMCPMC5974349

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.